Hisilicon (002653.SZ) successfully passed the Shenzhen Stock Exchange's review of its stock issuance application.

Intelligence Financial APP News, Hisilicon (002653.SZ) announced that on December 18, 2025, the company received the "Notice Letter on Opinions of the Shanghai Stock Exchange Listing Review Center on the Application of Hisilicon Pharmaceutical Group Co., Ltd. to Issue Stocks to Specific Objects". The Shanghai Stock Exchange Listing Review Center reviewed the application documents for issuance of stocks to specific objects submitted by the company, and believed that the company meets the issuance conditions, listing conditions, and information disclosure requirements. Subsequently, the Shanghai Stock Exchange will report to the China Securities Regulatory Commission to carry out relevant registration procedures according to regulations.